Navigation Links
Further Studies on AIDS Prevention Gels Stopped

Researchers have discontinued further studies on anti-AIDS vaginal gel in Africa and India, following results of recent trials, which indicated// that it could enhance the risk of HIV infection, instead of reducing it.

The gel in question, called Ushercell, contains a cotton-based compound called cellulose sulfate. This gel is developed by Polydex Pharmaceuticals, a company in Toronto.

More than 50% of AIDS infections in Africa concern women and girls. Researchers have been contemplating the employment of other protective measures which could be used by women, even without the knowledge of their partners. Scientists thought this would help in the scenario of many men refusing to use any protection during sex.

A study with 1,500 women in South Africa, Benin, Uganda, and India had to be halted during this week after a supervising board observed an increase in HIV infections among women using the gel, in contrast to women who were given an inactive medication.

"I cannot think of any biological basis for these findings, and I hope that further analysis of all of the data may shed further light on this important question," said USAID's research chief, Jeff Spieler.

"We did not find any evidence of greater risk of HIV infection," said a statement from Dr. Vera Halpern, who had spearheaded the Nigeria study. "But we also found no evidence that the product was effective."

Almost eleven trials had been conducted in The United States to evaluate the effectiveness of this gel, which had found the product to be safe and effective.
'"/>




Page: 1

Related medicine news :

1. Further support for use of statins in Alzheimer’s disease
2. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
3. Doctor Accused Of Misdiagnosing 208 Patients: Further Investigation Ordered
4. NHS Recommends Further Cost Cutting Measures
5. Medha Patkars Condition Deteriorates Further
6. Oxford Radcliffe Hospitals Warns Of Further Job Losses
7. Further Studies Needed To Completely Understand About Ventricular Fibrillation
8. Further improvements envisaged at Carstairs
9. UCLA Find Yields Further Insight into Causes of Parkinson’s Diseas
10. Salt Consumption Needs To Drop Further
11. Studies On Hearing Loss Discovers New Causes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... , ... March 24, 2017 , ... The law firm ... Plains, N.Y., is pleased to announce Westchester resident Lauren C. Enea has joined the ... for the firm, will concentrate her practice in elder law, Medicaid planning and applications, ...
(Date:3/24/2017)... ... March 24, 2017 , ... Judy Buchanan, co-owner of ... Frederick, MD. Judy says, “I am passionate about sharing Reiki as a holistic, ... difficult and challenging time.” , A Certified Medical Reiki™ Master trained by Raven ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of Saints: A ... God in congregations across the United States. “The Communion of Saints” is ... who has served congregations in seven states throughout his long career of devotion ...
(Date:3/23/2017)... ... March 23, 2017 , ... The physicians of KSF ... the greater Houston Area. The new location is located at 2255 E. Mossy Oaks ... Springwoods Village. This newest location will provide patients living in the north Houston area ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The IoT ... and WiFi connectivity are making a huge impact on businesses and individual consumers alike. ... estimates the IoT will have a value anywhere from $4 trillion to $11 trillion ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017  Zymo Research Corp., also known ... Inc., who designs, manufactures and distributes liquid ... teams Zymo Research,s DNA methylation detection and ... products with Hamilton,s high-throughput automation platforms. Zymo ... microbiomics and RNA isolation for use on ...
(Date:3/24/2017)... , March 24, 2017   The ... organization within medical affairs in the pharmaceutical industry ... the chair of a newly formed scientific advisory ... members to form the first ever medical affairs ... For more information about the ACMA, please visit  ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
Breaking Medicine Technology: